510(k) K210126

Sodium Chloride Inhalation Solutions, 3%, 3.5%, 7% and 10% by The Ritedose Corporation — Product Code CAF

K210126 is an FDA 510(k) premarket notification submitted by The Ritedose Corporation for the device "Sodium Chloride Inhalation Solutions, 3%, 3.5%, 7% and 10%". The FDA issued a decision of Substantially Equivalent on Dec 3, 2021. The device falls under product code CAF (Nebulizer (Direct Patient Interface)), a Class II device regulated under 21 CFR 868.5630.

Clearance details

Decision
SESE (Substantially Equivalent)
Decision Date
Dec 3, 2021
Date Received
Jan 19, 2021
Clearance Type
Traditional
Expedited Review
No
Third Party Review
No

Device classification

Device Name
Nebulizer (Direct Patient Interface)
Device Class
Class II
Regulation Number
868.5630
Review Panel
AN
Submission Type
510(k)

Source: FDA 510(k) database entry for K210126. Report a data issue: hello@regdatalab.com.